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Editorial
Combined percutaneous treatment of structural and congenital heart defects:  
more than just a feasible procedure in the catheterization laboratory
Tratamento percutâneo combinado de defeitos cardíacos estruturais e congênitos:  
mais do que apenas um procedimento viável no laboratório de cateterismo
In this issue of the Revista Brasileira de Cardiologia Invasiva, 
Chamié et al.1 describe an interesting series of ten cases in which 
combined percutaneous treatment of structural and congenital 
heart defects were performed by the authors. The procedures in-
cluded closure of atrial septal defect (ASD), ventricular septal defect 
(VSD), left atrial appendage (LAA), and patent ductus arteriosus 
(PDA), patent foramen ovale (PFO), as well as pulmonary balloon val-
vuloplasty, treatment of aortic coarctation and aortopulmonary col-
laterals embolization. Closure of PDA was the most common 
intervention and the two most frequent combined procedures were 
VSD with PDA and VSD with ASD, each contributing with two cases.
Descriptive studies of combined congenital and structural proce-
dures have been sporadically reported in the literature. Hamid et al. 
presented a similar series of cases, describing the successful correc-
tion of congenital heart defects in eight patients.2 To note, their 
study included only adult patients and had a shorter follow-up 
period, in comparison to the series of Chamié et al. Regarding non-
congenital structural heart interventions, several single case-re-
ports have been described, such as a simultaneous LAA closure and 
transcatheter aortic valve intervention (TAVI) under cerebral protec-
tion.3 The scarce literature on combined structural interventions 
and congenital structural procedures probably reflects the com-
plexity of these procedures and relative low prevalence of these pa-
thologies, in comparison to e.g. coronary disease. 
This field is crawling in the generation of evidence to push the 
boundaries of current practice. The description of case-reports and 
case series is the first step to change, while more powerful study 
designs cannot be implemented. The procedural success rate and clin-
ical outcomes presented by Chamié et al. were excellent, albeit they 
were mostly not complex procedures that demanded long interven-
tional times. Nevertheless, the combined procedures presented are 
not the “bread and butter” case of a catheterization laboratory. Con-
sidering that procedural performance and clinical outcomes were the 
same as if the procedures were to be performed separately, what is 
the leap forward in this case series?
We believe that there are at least a few definitive advantages and 
some potential ones. Firstly, percutaneous structural interventions 
are becoming globally more frequent and with a trend to increase in 
the next few years.4  That is also true for congenital interventions, 
considering the aging population of patients with congenital heart 
defects and consequently increase in prevalence.5 TAVI and other 
adult cardiac structural interventions are advancing over otherwise 
surgical procedures, as mitral valve procedures and aortic valve re-
placement. Simpler procedures, as ASD, PFO and LAA closures, are 
performed almost exclusively in the cath lab. This ought to become 
true for more complex interventions as well. As a result of the in-
crease in the frequency of percutaneous structural procedures, 
which usually demand longer preparation periods (room setup, pa-
tient preparation, anesthesia/sedation and imaging), time optimiza-
tion in the catheterization laboratory is welcome.
The second and maybe most compelling aspect of Chamié et al. 
work is patient preference and comfort. Children with congenital 
heart defects represent a special concern regarding parents, cath lab 
staff and especially the emotional burden on younger patients, fre-
quently too young to understand the procedure and all manipula-
tion involved. In this population, safely avoiding staged procedures 
through combined interventions is a major step forward.
Finally, from a cost-effectiveness perspective in the Brazilian 
health-care scenario, it is most likely interesting for health insur-
ance companies to have two interventions done in the same day 
instead of allocating personnel and cath lab resources in two sepa-
rate procedures. This is especially valid considering public hospitals 
in Brazil and their budget constraints.
The potential application of combined structural procedures is 
vast, although there are limitations for more complex interventions. 
Longer procedures may incur in typical surgical issues, as for exam-
ple longer intubation periods and its consequences, especially con-
sidering patients with severe lung disease. Renal failure secondary 
to increased use of contrast dye and periprocedural cerebral embo-
lism and stroke, secondary to multiple structural heart procedures 
that include transseptal puncture for closure of the LAA or mitral 
valve interventions, are other potential limitations. As patients with 
multivessel complex coronary disease will most probably be sub-
mitted to a staged procedure, the same is valid for structural and 
congenital interventions. The feasibility has to be assessed consider-
ing the type of intervention and patient characteristics. Overall, 
combined procedures for multiple acquired and congenital heart 
defects may be a glimpse of what future holds for percutaneous 
structural cardiac interventions.
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